Rivian (NASDAQ: RIVN) and Lucid (NASDAQ: LCID) could benefit from increasing tariffs impacting larger car companies more severely. *Stock prices used were the afternoon prices of April 6, 2025. The ...

Following Lucid stock's latest rally, Finbold consulted the DeepSeek R1 AI model on how LCID might fare by the end of 2025.

Where there's smoke, there's fire, and it's clear that Tesla has hit a speed bump due to previously mentioned developments.

Lucid Diagnostics (LUCD) has announced the pricing of a public offering of 12.5 million shares of its common stock at $1.20 per share, for gross proceeds of approximately $15 million.

Lucid Diagnostics Inc. shares (LUCD) tumbled more than 21% in after-hours trading Wednesday after the medical diagnostics ...

Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced the ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

Yet Lucid stock plunged by double digits in February as fears about the company's prospects mounted after a top management ...

It might seem like investors in Lucid Group (NASDAQ: LCID) can't catch a break these days. After years of disappointing results, slow delivery growth, and production hiccups and delays, the young ...

Raymond James Financial Inc. purchased a new stake in Lucid Group, Inc. (NASDAQ:LCID – Free Report) during the fourth quarter ...

Commonwealth Equity Services LLC lessened its holdings in shares of Lucid Group, Inc. (NASDAQ:LCID – Free Report) by 3.6% in the 4th quarter, according to its most recent filing with the SEC. The fund ...

The latest trading session saw Lucid Group (LCID) ending at $2.28, denoting a -1.72% adjustment from its last day's close. The stock's change was more than the S&P 500's daily loss of 5.98%. On the ...